YZ
Yun Zhong Wedbush Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
43%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
81%
Neutral
19%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $2 |
10%
downside
| 1 | +64% |
–
| 8 Jan ‘26 7 hours ago |
|
|
|
Outperform
Maintained
| $33 |
124%
upside
| 3 | +44% |
0
%
| 12 Dec ‘25 27 days ago |
|
|
|
Outperform
Initiated
| $32 |
37%
upside
| 1 | +7.4% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Outperform
Reiterated
| $220 |
5%
upside
| 3 | +7.9% |
0
%
| 18 Nov ‘25 1 month ago |
|
|
|
Neutral
Maintained
| $16 |
12%
downside
| 3 | – |
–
| 6 Nov ‘25 2 months ago |
|
|
|
Outperform
Initiated
| $8 |
296%
upside
| 1 | +5.2% |
0
%
| 29 Oct ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $86 |
8%
upside
| 2 | +30% |
0
%
| 28 Oct ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $18 |
26%
upside
| 1 | +130% |
0
%
| 30 Sep ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $40 |
116%
upside
| 1 | +230% |
0
%
| 13 Aug ‘25 4 months ago |
|
|
|
Outperform
Initiated
| $28 |
393%
upside
| 1 | -35% |
0
%
| 11 Aug ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $8 |
98%
upside
| 2 | +2.4% |
0
%
| 7 Aug ‘25 5 months ago |
|
|
|
Outperform
Initiated
| $8 |
27%
upside
| 1 | +220% |
0
%
| 27 May ‘25 7 months ago |
|
|
|
Outperform
Reiterated
| $32 |
744%
upside
| 1 | -43% |
0
%
| 16 May ‘25 7 months ago |
|